SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-096053
Filing Date
2018-03-26
Accepted
2018-03-26 16:49:50
Documents
68
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d488401d10k.htm 10-K 750388
2 EX-23.1 d488401dex231.htm EX-23.1 1919
3 EX-31.1 d488401dex311.htm EX-31.1 9265
4 EX-32.1 d488401dex321.htm EX-32.1 3658
11 GRAPHIC g488401g0321125051478.jpg GRAPHIC 193159
12 GRAPHIC g488401g0321125051712.jpg GRAPHIC 18702
13 GRAPHIC g488401g0321125051899.jpg GRAPHIC 105150
  Complete submission text file 0001193125-18-096053.txt   3863316

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxii-20171231.xml EX-101.INS 441737
6 XBRL TAXONOMY EXTENSION SCHEMA rxii-20171231.xsd EX-101.SCH 38955
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20171231_cal.xml EX-101.CAL 65289
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20171231_def.xml EX-101.DEF 150122
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20171231_lab.xml EX-101.LAB 350612
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20171231_pre.xml EX-101.PRE 260766
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 18713289
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences